Mechanisms mediating the effects of IL-3 gene expression on tumor growth

Y Z Wu1, J H Hong, H H Huang

  • 1Department of Atomic Science, Tsing Hua University, Hsinchu, Taiwan.

Insights

Interleukin-3 (IL-3) gene expression in tumors enhances immune cell infiltration and slows tumor growth. Tumor cells themselves, not just immune cells, may be key drivers of this slower growth.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Interleukin-3 (IL-3) gene expression in tumors influences host-cell infiltration, particularly macrophages, leading to slower tumor growth and enhanced immunogenicity.
  • Tumor-associated macrophages (TAMs) within FSAN-JmIL3 tumors exhibited reduced expression of TNF-alpha and iNOS, suggesting in vivo priming.

Purpose of the Study:

  • To investigate the mechanisms behind slower tumor growth in IL-3 expressing tumors.
  • To determine the role of TAMs and tumor cell responses to effector molecules.

Main Methods:

  • Analysis of TAMs from FSAN-JmIL3 tumors for TNF-alpha and iNOS expression.
  • Short-term culture of TAMs to assess functional recovery.
  • In vitro experiments to evaluate TAM stimulation by tumor cells.
  • Assessment of tumor cell responses to TNF-alpha and NO.

Main Results:

  • TAMs from FSAN-JmIL3 tumors showed decreased TNF-alpha and iNOS expression but regained function in culture.
  • In vitro studies did not reveal differences in TAM stimulation between FSAN-JmIL3 and FSAN tumor cells.
  • TNF-alpha and NO were cytotoxic to FSAN-JmIL3 cells but growth-stimulatory for FSAN cells.

Conclusions:

  • Tumor cell-intrinsic responses to TNF-alpha and NO significantly contribute to slower tumor growth.
  • Phenotypic changes in tumor cells play a crucial role in modulating tumor growth, potentially more than host cell infiltration changes.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...